Anesthetic Management for Renal Transplantation .

Kim,  Jin Moo; Cheun,  Jae Kyu

doi:1988.21.5.795

Clinical Research Article

Korean Journal of Anesthesiology 1988;21(5):795-801.
DOI: https://doi.org/10.4097/kjae.1988.21.5.795

Anesthetic Management for Renal Transplantation .

Jin Moo Kim, Jae Kyu Cheun

Department of Anesthesiology, Keimyung University, School of Medicine, Taegu, Korea.

Abstract

Dialysis and transplantation are the only therapies available for patients with the end stage of renal diseases. Transplantation offers several distinct advantages; the trans-plantation patient has an opportunity of regaining normal kidney functions, he can avoid the recurrent and enervating need for twice weekly dialysis, dieary and fluid restrictions can be removed, anemia, bone disease and neuropathy may be rapidly reversed, growth may occur in children and the long term costs of treatment are substantially reduced. Since the initial report on anesthesia for renal transplantation from the peter Bent Brigham Hospital in 1962, anesthesia for kidney transplantation has been reviewed and discussed by many authors. This report is concerned with our clinical experience of 55 cases of anesthesia for living donor renal transplantations at Dong San Medical Center during the period between November 1982 and December 1987. The results are summarized as follow: 1) The age incidence of recipients was prevalent in the 3rd to 4th decade and the ratio of males to females was 37:18. 2) The age incidence of donors was prevalent in the 3rd to 4th decade and the ratio of males to females was 22:33. Of 55 cases, 30 cases involved a parent to child donor relationship, younger brother, elder and younger sister were donors in 18 cases and 6 cases were non-related. 3) The overall one and two year transplantation survivals were 91.9% and graft survivals were 87.2% and 75.9% respectively. 4) Succinylcholine and vecuronium were used for intubation and maintenance of muscle relaxation. 5) Lower concentrations of halothane and nitrous oxide were used as inhalation anesthetics in most, except in HBs Ag(+) patients. In hepatitis patients, enflurane were used.

Key Words: Transplantation; Kidney; Management; Anesthetics